Company Overview of Adare Pharmaceuticals, Inc.
Adare Pharmaceuticals, Inc. develops, manufactures, and markets pharmaceutical products for customers worldwide. It develops Lactéol, a proprietary combination of Lactobacillus fermentum and Lactobacillus delbrueckii, and fermented culture medium (neutralized), which is used in addition to rehydration and dietary measures, as a symptomatic supplemental treatment for diarrhea in adults and children. The company also develops products for various therapeutic categories, such as cardiovascular, pain management, GI, and CNS; taste masking and orally disintegrating tablets, drug release products, and bioavailability enhancement products; and Rx and orally disintegrating tablets. It offers its pro...
Princeton Pike Corporate Center
1200 Lenox Drive
Lawrenceville, NJ 08648
Key Executives for Adare Pharmaceuticals, Inc.
Chief Executive Officer and President
Chief Financial Officer and Vice President of Finance
Chief Medical Officer and Vice President of Research & Development
Vice President of Human Resources
Vice President of Commercial & Strategic Development
Compensation as of Fiscal Year 2017.
Adare Pharmaceuticals, Inc. Key Developments
Adare Pharmaceuticals, Inc. Presents at BIO International Conference 2017, Jun-21-2017 01:30 PM
May 27 17
Adare Pharmaceuticals, Inc. Presents at BIO International Conference 2017, Jun-21-2017 01:30 PM. Venue: San Diego Convention Center, San Diego, California, United States.
Adare Pharmaceuticals, Inc. Presents at 9th Annual Conference Biotech Showcase, Jan-09-2017
Dec 20 16
Adare Pharmaceuticals, Inc. Presents at 9th Annual Conference Biotech Showcase, Jan-09-2017 . Venue: Hilton San Francisco Union Square, 333 O'Farrell Street, San Francisco, California, United States.
Adare Pharmaceuticals Appoints Dr. Peter Richardson as Vice President, Research & Development and Chief Medical Officer
Nov 7 16
Adare Pharmaceuticals, Inc. announced that Dr. Peter Richardson has joined the company as Vice President, Research & Development and Chief Medical Officer. Dr. Richardson will be
responsible for leading the Research and Development efforts worldwide and for the successful development of the company’s pipeline. Dr. Richardson brings 30 years of medical practice, research and development experience in the pharmaceutical and medical device industry. He joins the team from Novartis Corporation where he was most recently the Chief Medical Officer for its eye care division Alcon. In this role he held multiple responsibilities including leading the company's clinical, regulatory and safety organizations globally and serving as its ad-interim head of research and development for its Pharmaceutical business.
Similar Private Companies By Industry
Recent Private Companies Transactions